Skip to main content
SpringerLink
Log in

Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Preliminary reports involving a number of different kinds of tumors have indicated that microvessel quantification may be useful in predicting disease outcome. The aim of this study was to examine the relationship between microvessel density (MVD) as a parameter of tumor angiogenesis and the response to chemotherapy in diffuse large B-cell (DLBC) lymphomas.

A total of 36 DLBC lymphoma patients were evaluated, 23 of them with a chemosensitive; responsive disease (median survival 8 y) and 13 with a chemoresistant, refractory disease (median survival 8 months). Microvessel quantification was performed by immunohistochemical staining, using monoclonal antibodies against factor VIII related antigen (F8RA) and against platelet/endothelial cell adhesion molecule-CD31.

We found that F8RA stained a significantly higher number of blood vessels (about 2.5 times more) than CD-31; 7 samples were not stained with CD-31 but were positive for F8RA. There was no significant difference between the density of microvessel staining of the two groups. In the chemosensitive DLBC lymphomas positive for F8RA, the mean number of microvessels stained was 54.5±36.1 per microscopic field (200×) examined (range 6–149) whereas in the chemoresistant group the corresponding mean number was 43.1±25.5 (range 11–94).

F8RA appears to be more sensitive for staining DLBC lymphomas microvessels than CD-31. Our data demonstrate that there is no correlation between tumor MVD and response to chemotherapy in patients with DLBC lymphomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Folkman J. Clinical application of research on angiogenesis.New Engl J Med 1995;333: 1757–1763.

    Article  CAS  PubMed  Google Scholar 

  2. Pluda JM. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies.Semin Oncol 1997;24: 203–218.

    CAS  PubMed  Google Scholar 

  3. Folkman J. What is the evidence that tumors are angiogenesis dependent?J Natl Cancer Inst 1990;82: 4–6.

    Article  CAS  PubMed  Google Scholar 

  4. Baillie CT, Winslet MC, Bradley NJ. Tumor vasculature a potential therapeutic target.Br J Cancer 1995;72: 257–267.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: more than a new prognostic tool.J Clin Oncol. 1995;13: 765–782.

    Article  CAS  PubMed  Google Scholar 

  6. Weidner Net al. Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma.J Natl Cancer Inst 1992;84: 1875–1887.

    Article  CAS  PubMed  Google Scholar 

  7. Bochner BHet al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.J Natl Cancer Inst 1995;87: 1603–1612.

    Article  CAS  PubMed  Google Scholar 

  8. Hollingsworth HCet al. Tumor angiogenesis in advanced stage ovarian carcinoma.Am J Pathol 1995;147: 33–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Kaku Tet al. Angiogenesis in endometrial carcinoma.Cancer 1997;80: 741–747.

    Article  CAS  PubMed  Google Scholar 

  10. Fontanini Get al. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.J Natl Cancer Inst 1997;89: 881–886.

    Article  CAS  PubMed  Google Scholar 

  11. roychowdhury DFet al. New prognostic factors in nasopharyngeal carcinoma.Cancer 1996;77: 1419–1426.

    Article  CAS  PubMed  Google Scholar 

  12. Lindmark Get al. Prognostic significance of the microvascular count in colorectal cancer.J Clin Oncol 1996;14: 461–466.

    Article  CAS  PubMed  Google Scholar 

  13. Tanigawa Net al. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas.Cancer Res 1996;56: 2671–2676.

    CAS  PubMed  Google Scholar 

  14. Gasparini Get al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma.Int J Cancer 1993;55: 739–744.

    Article  CAS  PubMed  Google Scholar 

  15. Foss AJet al. Microvessel count predicts survival in uveal melanoma.Cancer Res 1996;56: 2900–2903.

    CAS  PubMed  Google Scholar 

  16. Weidner N. Intratumor microvessel density as a prognostic factor in cancer.Am J Pathol 1995;147: 9–19.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Ribatti Det al. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphoma. An immunohistochemical and ultrastructural study.Eur J Haematol 1996;56: 45–33.

    Article  CAS  PubMed  Google Scholar 

  18. Vacca Aet al. Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas.Br J Cancer 1999;79: 965–970.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Harris NLet al. A revised European-American classification of lymphoid neoplasms: a proposal from the international Lymphoma Study Group.Blood 1994;84: 1361–1392.

    Article  CAS  PubMed  Google Scholar 

  20. Vermeulen PBet al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation.Eur J Cancer 1996;32A: 2474–2484.

    Article  CAS  PubMed  Google Scholar 

  21. Perez-Atayde ARet al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.Am J Pathol 1997;150: 815–821.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Vacca Aet al. Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLAQ-4, LAM-1, and CD44.Am J Hamatol 1995;50: 9–14.

    Article  CAS  Google Scholar 

  23. Vacca Aet al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma.Blood 1999;93: 3064–3073.

    Article  CAS  PubMed  Google Scholar 

  24. Rajkumar SV, Fonseca R, Witzig TEet al. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.Leukemia 1999;13: 469–472.

    Article  CAS  PubMed  Google Scholar 

  25. Singhal Set al. Antitumor activity of thalidomide in refractory multiple myeloma.New Engl J Med 1999;341: 1565–1571.

    Article  CAS  PubMed  Google Scholar 

  26. salven P, Teerenhovi L, Joensuu H. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma.Blood 1999;94: 3334–3339.

    Article  CAS  PubMed  Google Scholar 

  27. Salven P, Teerenhovi L, Joensuu H. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma.Blood 1997;90: 3167–3172.

    Article  CAS  PubMed  Google Scholar 

  28. Bertolini Fet al. Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma.Br J Haematol 1999;106: 504–509.

    Article  CAS  PubMed  Google Scholar 

  29. Bairey O, Zimra Y, Shaklai Met al. Expression of Bcl-2, Bcl-X, Bax and Bak proteins in short and long-lived patients with diffuse large B-cell lymphomas.Clin Cancer Res 1999;5: 2860–2866.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Hematology, Rabin Medical Center, Beilinson Campus, 49100, Petah-Tikva, Israel

    O Bairey, Y Zimra, M Shaklai & E Rabizadeh

  2. Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, 49100, Petah-Tiqva, Israel

    O Bairey, Y Zimra, M Shaklai & E Rabizadeh

  3. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    O Bairey, Y Zimra, E Kaganovsky, M Shaklai, E Okon & E Rabizadeh

  4. Pathology and the Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel

    E Kaganovsky & E Okon

Authors
  1. O Bairey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Zimra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Kaganovsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Shaklai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Okon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E Rabizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O Bairey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bairey, O., Zimra, Y., Kaganovsky, E. et al. Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas. Med Oncol 17, 314–318 (2000). https://doi.org/10.1007/BF02782197

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02782197

Keywords

Search

Navigation